Actemra™ Has A Major Impact On Improving Remission Rates In Rheumatoid Arthritis - 3 Studies From The Japanese Phase III Trial Programme
13th Nov 2006, 08:27 GMT
On the 13th November 2006, impressive results will be presented at ACR, the American College of Rheumatology, Washington D. C. These data highlight the outstanding symptom control with Actemra (tocilizumab) monotherapy for patients with rheumatoid arthritis (RA). [click link for full article]
Actemra™ Has A Major Impact On Improving Remission Rates In Rheumatoid Arthritis - 3 Studies From The Japanese Phase III Trial Programme related news:
- New Study Shows ACTEMRA(TM) (tocilizumab) Significantly Improves Remission Rates In Patients With Rheumatoid Arthritis — Health News from Medical News Today
- ACR: Aggressive Initial Therapy Can Send Rheumatoid Arthritis Into Remission — MedPage Today Rheumatology
- Early Aggressive Treatment May Alter Course Of Rheumatoid Arthritis — Health News from Medical News Today
- Mayo Clinic information about accelerated aging among people with rheumatoid arthritis — EurekAlert! - Breaking News
- Accelerated Aging Among People With Rheumatoid Arthritis — ScienceDaily Headlines: Health & Medicine
- Anti-TNF Golimumab (CNTO 148) Continues To Show Promise In Phase 2 Rheumatoid Arthritis Study — Health News from Medical News Today
- Treat Rheumatoid Arthritis Early — WebMD Health Headlines
- Impact Of Rheumatoid Arthritis Goes Beyond Signs And Symptoms, Delay In Treatment May Impact Long-Term Employment — Health News from Medical News Today
- New Information About Accelerated Aging Among People With Rheumatoid Arthritis — Health News from Medical News Today
- Adalimumab Proves Effective For Children With Juvenile Rheumatoid Arthritis — Health News from Medical News Today
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes